Beta Bionics Inc. (BBNX)
NASDAQ: BBNX
· Real-Time Price · USD
21.13
-1.21 (-5.42%)
At close: Oct 15, 2025, 3:59 PM
21.13
0.00%
After-hours: Oct 15, 2025, 04:10 PM EDT
-5.42% (1D)
Bid | 20.41 |
Market Cap | 918.52M |
Revenue (ttm) | 78.02M |
Net Income (ttm) | -73.37M |
EPS (ttm) | -1.69 |
PE Ratio (ttm) | -12.5 |
Forward PE | -12.31 |
Analyst | Buy |
Dividends | n/a |
Ask | 22.99 |
Volume | 543,121 |
Avg. Volume (20D) | 767,617 |
Open | 22.49 |
Previous Close | 22.34 |
Day's Range | 21.05 - 22.50 |
52-Week Range | 8.89 - 26.66 |
Beta | 5.68 |
Ex-Dividend Date | n/a |
About BBNX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BBNX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BBNX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+14.32%
Beta Bionics shares are trading higher after the c...
Unlock content with
Pro Subscription
5 months ago
+26.61%
Beta Bionics shares are trading higher after the company reported better-than-expected Q1 sales results and raised its FY25 guidance with its midpoint above estimates.